NOV 14, 2019 3:59 PM PST

Specific gut bacteria linked to bowel cancer

New research suggests that the presence of a certain kind of gut bacteria can increase the risk of bowel cancer by as much as 15%. The research is important in that it actually determines a causal effect – not merely an association – meaning that it suggests that certain bacteria in our guts may cause colorectal cancer. Lead author of the study Kaitlin Wade, Ph.D., from the UK’s University of Bristol, presented the research at the National Cancer Research Institute Cancer Conference in Glasgow.

In conducting the study, Wade and fellow researchers analyzed data from several large datasets – collected from the Flemish Gut Flora Project, the German Food Chain Plus study, the PopGen study, and the international Genetics and Epidemiology of Colorectal Cancer Consortium. In total, they compared the genomes of 124,218 individuals to attempt to determine causality between gut bacteria and colorectal cancer.

"Lots of studies in mice and humans have shown an association between the gut microbiome and bowel cancer," explains Wade, "but very few have provided convincing evidence for causality. In other words, it's really difficult to discern whether components of the gut microbiome can cause bowel cancer, whether the disease itself leads to variation in the gut microbiome, or whether the association is due to some other factors that cause variation in both."

The other factors that Wade is referring to include obesity, lack of physical exercise, smoking, high consumption of red meat and fried foods, as well as age, family history, and IBS. Along with gut bacteria, these factors will result in the diagnosis of more than 100,000 new cases of colon cancer and more than 44,000 new cases of rectal cancer in the United States in 2019, making the combined category of these cancers (called colorectal cancer), the third leading cause of cancer death in both men and women.

Photo: New Atlas

To confirm causality, the research team used a statistical method called Mendelian randomization that allowed them to pinpoint how certain bacteria influence health conditions, without having to involve actual individuals’ lives.

Wade explains, "With Mendelian randomization, we use people's natural, randomly inherited genetic variations, which alter levels of bacteria within the gut microbiome, in a way that mimics a randomized trial. In this way, we don't have to edit anyone's gut microbiome directly by giving antibiotics or probiotics in a randomized trial or waste time waiting to see whether people within the population get colorectal cancer. We just need studies that have already got this information measured," she explains.

This analysis determined that a specific kind of bacteria called Bacteroidales increased the risk of bowel cancer by between 2–15%, showing that the presence of Bacteroidales is greater in those people with colorectal cancer. Although this finding is promising, the researchers hope to continue their investigations, stating that more work is needed to broaden our understanding of gut bacteria’s influence on bowel cancer.

Sources: Medical News Today, National Cancer Research Institute 

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 22, 2021
Cancer
Whole Genome Sequencing for Cancer Diagnostics
SEP 22, 2021
Whole Genome Sequencing for Cancer Diagnostics
The human genome consists of genetic material known as DNA.  We all have unique DNA sequences made up of four bases ...
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
DEC 02, 2021
Clinical & Molecular DX
Gut Bacteria Slip Into the Pancreas, Cause Cancer
DEC 02, 2021
Gut Bacteria Slip Into the Pancreas, Cause Cancer
  Scientists have connected the dots between bacteria in the digestive system and an increased risk of malignant pa ...
Loading Comments...